Clinical Trial Update: ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of an extended-release formulation of oxcarbazepine (Apydan Extent) in patients with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Apydan Extent (oxcarbazepine extended-release)

Snippet

Sponsor: Desitin Arzneimittel GmbH | Conditions: Epilepsy | Status: COMPLETED